ZA200903173B - Cancer susceptibility variants on chr8q24.21 - Google Patents

Cancer susceptibility variants on chr8q24.21

Info

Publication number
ZA200903173B
ZA200903173B ZA2009/03173A ZA200903173A ZA200903173B ZA 200903173 B ZA200903173 B ZA 200903173B ZA 2009/03173 A ZA2009/03173 A ZA 2009/03173A ZA 200903173 A ZA200903173 A ZA 200903173A ZA 200903173 B ZA200903173 B ZA 200903173B
Authority
ZA
South Africa
Prior art keywords
cancer susceptibility
susceptibility variants
variants
cancer
susceptibility
Prior art date
Application number
ZA2009/03173A
Other languages
English (en)
Inventor
Juluis Gudmundsson
Patrick Sulem
Augustine Kong
Andrei Manolescu
Laufey Amundadottir
Original Assignee
Decode Genetics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Decode Genetics filed Critical Decode Genetics
Publication of ZA200903173B publication Critical patent/ZA200903173B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA2009/03173A 2006-10-27 2009-05-07 Cancer susceptibility variants on chr8q24.21 ZA200903173B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IS8560 2006-10-27
PCT/IS2007/000019 WO2008050356A1 (en) 2006-10-27 2007-10-26 Cancer susceptibility variants on chr8q24.21

Publications (1)

Publication Number Publication Date
ZA200903173B true ZA200903173B (en) 2010-02-24

Family

ID=39060300

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2009/03173A ZA200903173B (en) 2006-10-27 2009-05-07 Cancer susceptibility variants on chr8q24.21

Country Status (13)

Country Link
US (1) US20100129799A1 (enExample)
EP (1) EP2089548A1 (enExample)
JP (1) JP5631000B2 (enExample)
CN (1) CN101641451A (enExample)
AU (1) AU2007310412B2 (enExample)
BR (1) BRPI0718322A2 (enExample)
CA (1) CA2667737A1 (enExample)
IL (1) IL198305A0 (enExample)
MX (1) MX2009004522A (enExample)
NZ (1) NZ576591A (enExample)
SG (1) SG175680A1 (enExample)
WO (1) WO2008050356A1 (enExample)
ZA (1) ZA200903173B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12366585B2 (en) 2006-05-18 2025-07-22 Caris Mpi, Inc. Molecular profiling of tumors
BRPI0807236A2 (pt) * 2007-02-07 2019-09-24 Decode Genetics Ehf métodos para determinar uma suscetibilidade para câncer de próstata em um indivíduo humano, para identificar um marcador para uso em avaliação de suscetibilidade para câncer de próstata e para genotipificar uma amostra de ácido nucleico obtida de um indivíduo humano sob risco de, ou diagnosticado com, câncer de prostáta, para avaliar um indivíduo humano para probabiliade da resposta a um agente terapêutico para prevenir e/ou melhorar sintomas associados com câncer de próstata, para predizer prognóstico de um indivíduo diagnosticado com câncer e para monitorar progresso de um tratamento de um indivíduo sofrendo tratamento para câncer de próstata, kit para avaliar suscetibilidade para câncer de próstata em um indivíduo humano, uso de uma sonda de oligonucleotídeo, meio legível por computador, e , aparelho para determinar um indicador genético para câncer de próstata em um indivíduo humano.
JPWO2008130008A1 (ja) 2007-04-17 2010-07-22 木下　茂 緑内障発症リスクの判定方法
US8697360B2 (en) 2007-11-30 2014-04-15 Decode Genetics Ehf. Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition
US20090226912A1 (en) * 2007-12-21 2009-09-10 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
CA2729934A1 (en) * 2008-07-07 2010-01-14 Decode Genetics Ehf Genetic variants for breast cancer risk assessment
US8583380B2 (en) 2008-09-05 2013-11-12 Aueon, Inc. Methods for stratifying and annotating cancer drug treatment options
CN106153918A (zh) * 2008-10-14 2016-11-23 卡里斯Mpi公司 描绘肿瘤类型生物标志模式和特征集的基因靶和基因表达的蛋白靶
WO2010128530A1 (en) * 2009-05-08 2010-11-11 Decode Genetics Ehf Genetic variants contributing to risk of prostate cancer
WO2011004404A1 (en) * 2009-07-10 2011-01-13 Decode Genetics Ehf Genetic variants for predicting risk of glaucoma
WO2011009089A1 (en) * 2009-07-17 2011-01-20 Ordway Research Institute, Inc. SMALL NON-CODING REGULATORY RNAs AND METHODS FOR THEIR USE
US20120316218A1 (en) * 2009-07-17 2012-12-13 Glinsky Gennadi V SMALL NON-CODING REGULARTORY RNA's and METHODS FOR THEIR USE
EP2494071A1 (en) 2009-10-26 2012-09-05 Abbott Laboratories Diagnostic methods for determining prognosis of non-small cell lung cancer
CA2777169C (en) 2009-10-26 2018-11-20 Abbott Laboratories Diagnostic methods for determining prognosis of non-small cell lung cancer
WO2012029080A1 (en) * 2010-08-30 2012-03-08 Decode Genetics Ehf Sequence variants associated with prostate specific antigen levels
US9732389B2 (en) 2010-09-03 2017-08-15 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
RU2565550C2 (ru) 2010-09-24 2015-10-20 Те Борд Оф Трастиз Оф Те Лилэнд Стэнфорд Джуниор Юниверсити Прямой захват, амплификация и секвенирование днк-мишени с использованием иммобилизированных праймеров
US9534256B2 (en) 2011-01-06 2017-01-03 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with risk of aggressive prostate cancer
EP2673380B1 (en) * 2011-02-09 2018-12-12 Bio-Rad Laboratories, Inc. Analysis of nucleic acids
CN102304567B (zh) * 2011-04-29 2013-03-27 广州益善生物技术有限公司 一种染色体8q24区段多态性检测特异性引物和液相芯片
WO2012178058A1 (en) * 2011-06-22 2012-12-27 Indiana University Research And Technology Corporation Compositions for and methods of detecting, diagnosing and prognosing thymic cancer
WO2013065072A1 (en) * 2011-10-30 2013-05-10 Decode Genetics Ehf Risk variants of prostate cancer
CN105555972B (zh) 2013-07-25 2020-07-31 伯乐生命医学产品有限公司 遗传测定
EP3341875A1 (en) * 2015-08-27 2018-07-04 Koninklijke Philips N.V. An integrated method and system for identifying functional patient-specific somatic aberations using multi-omic cancer profiles
KR101944927B1 (ko) 2016-03-24 2019-02-07 서울대학교산학협력단 전립선암과 관련된 단일염기다형성 및 이를 이용한 유전 위험도 점수의 개발
WO2017164699A1 (ko) * 2016-03-24 2017-09-28 서울대학교병원 (분사무소) 전립선암과 관련된 단일염기다형성 및 이를 이용한 유전 위험도 점수의 개발
CN106480211A (zh) * 2016-11-24 2017-03-08 深圳市核子基因科技有限公司 一种用于检测睾丸癌易感性的试剂盒及其snp标志物
US20190345565A1 (en) * 2017-02-01 2019-11-14 Phadia Ab Method for indicating a presence or non-presence of prostate cancer in individuals with particular characteristics
TW202033760A (zh) * 2018-11-28 2020-09-16 國立大學法人千葉大學 多因素遺傳疾病的基因檢測法、及檢測套件
EP3963092A1 (en) * 2019-05-02 2022-03-09 Predictive Technology Group, Inc. Somatic cancer driver mutations in endometriosis lesions contribute to secondary cancer risk
US20230119558A1 (en) * 2020-03-06 2023-04-20 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Dna damage repair genes in cancer
KR102177222B1 (ko) * 2020-04-24 2020-11-10 유니젠바이오 주식회사 머신러닝 기반 암진단 예측 시스템
KR102177218B1 (ko) * 2020-04-24 2020-11-10 유니젠바이오 주식회사 머신러닝 기반 암진단 예측 장치
KR20250074712A (ko) 2023-11-15 2025-05-28 주식회사 바스젠바이오 전립선암 발병의 위험도를 예측하기 위한 조성물 및 이를 이용한 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5384261A (en) * 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
AU785425B2 (en) * 2001-03-30 2007-05-17 Genetic Technologies Limited Methods of genomic analysis
AU2002324649A1 (en) * 2001-08-04 2003-02-24 General Hospital Corporation Haplotype map of the human genome and uses therefor
US20040023237A1 (en) * 2001-11-26 2004-02-05 Perelegen Sciences Inc. Methods for genomic analysis
US20040146870A1 (en) * 2003-01-27 2004-07-29 Guochun Liao Systems and methods for predicting specific genetic loci that affect phenotypic traits

Also Published As

Publication number Publication date
WO2008050356A1 (en) 2008-05-02
MX2009004522A (es) 2009-07-02
JP5631000B2 (ja) 2014-11-26
EP2089548A1 (en) 2009-08-19
AU2007310412B2 (en) 2013-02-14
AU2007310412A1 (en) 2008-05-02
IL198305A0 (en) 2010-02-17
NZ576591A (en) 2012-04-27
US20100129799A1 (en) 2010-05-27
BRPI0718322A2 (pt) 2013-11-26
SG175680A1 (en) 2011-11-28
CN101641451A (zh) 2010-02-03
CA2667737A1 (en) 2008-05-02
JP2010507388A (ja) 2010-03-11

Similar Documents

Publication Publication Date Title
IL198305A0 (en) Cancer susceptibility variants on chr8q24.21
GB2427560B (en) Cathether device
GB0601471D0 (en) The cardioprotector
IL194972A0 (en) 2-alkoxy-3,4,5-trihydroxy-alkylamide-
HK1135145A (en) Cancer susceptibility variants on chr8q24.21
GB0525698D0 (en) Eezeeband
GB0602141D0 (en) The turboramjet
PL381338A1 (pl) Kalibrator wytłaczarski
PL383280A1 (pl) Układ do sterowania urządzeń połączonych w sieć, sposób sterowania poprzez otwartą magistralę typu Feldbus urządzeń połączonych w sieć za pomocą magistrali oraz łącznik sterowany przez układ
GB0623056D0 (en) GeoDirk E.S.
GB0604245D0 (en) Rubaneck.com
GB0604054D0 (en) The handy-grab
GB0620205D0 (en) The scatter-light
GB0604276D0 (en) The t-stick
GB0609613D0 (en) The quitter
GB0603848D0 (en) The enfoPod
GB0612279D0 (en) The sockball
GB0624169D0 (en) The doubleback
GB0605170D0 (en) The Punch-Mate
GB0620678D0 (en) The degravitator
GB0603451D0 (en) The ring2protect
GB0712517D0 (en) The wonderstrap
IL172976A0 (en) C.i. armwrestling
GB0509859D0 (en) VirtualTrolley.Com
GB0517874D0 (en) Abacus